MedPath

OLAINFARM, PREDSTAVITELSTVO

🇷🇺Russia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:6
Completed:0

Trial Phases

1 Phases

Phase 1:6

Drug Approvals

7

CIMA_AEMPS:7

Drug Approvals

LENALIDOMIDA OLAINFARM 5 MG CAPSULAS DURAS EFG

Approval Date
Jul 14, 2025
CIMA_AEMPS

LENALIDOMIDA OLAINFARM 25 MG CAPSULAS DURAS EFG

Approval Date
Jul 14, 2025
CIMA_AEMPS

LENALIDOMIDA OLAINFARM 10 MG CAPSULAS DURAS EFG

Approval Date
Jul 14, 2025
CIMA_AEMPS

LENALIDOMIDA OLAINFARM 20 MG CAPSULAS DURAS EFG

Approval Date
Jul 14, 2025
CIMA_AEMPS

LENALIDOMIDA OLAINFARM 2,5 MG CAPSULAS DURAS EFG

Approval Date
Jul 14, 2025
CIMA_AEMPS

LENALIDOMIDA OLAINFARM 7,5 MG CAPSULAS DURAS EFG

Approval Date
Jul 14, 2025
CIMA_AEMPS

LENALIDOMIDA OLAINFARM 15 MG CAPSULAS DURAS EFG

Approval Date
Jul 14, 2025
CIMA_AEMPS

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Phase 1
6 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.